Pfizer cuts full-year outlook due to declining sales of Covid-19-related products
Shares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products ByMICHELLE CHAPMAN AP business writer…
Read more Pfizer cuts full-year outlook due to declining sales of Covid-19-related products